Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66 Street, New York, NY 10065, USA.
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
Contrast Media Mol Imaging. 2019 Nov 22;2019:2972189. doi: 10.1155/2019/2972189. eCollection 2019.
To investigate if histogram analysis and visually assessed heterogeneity of diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping can predict molecular subtypes of invasive breast cancers.
In this retrospective study, 91 patients with invasive breast carcinoma who underwent preoperative magnetic resonance imaging (MRI) with DWI at our institution were included. Two radiologists delineated a 2-D region of interest (ROI) on ADC maps in consensus. Tumors were also independently classified into low and high heterogeneity based on visual assessment of DWI. First-order statistics extracted through histogram analysis within the ROI of the ADC maps (mean, 10th percentile, 50th percentile, 90th percentile, standard deviation, kurtosis, and skewness) and visually assessed heterogeneity were evaluated for associations with tumor receptor status (ER, PR, and HER2 status) as well as molecular subtype.
HER2-positive lesions demonstrated significantly higher mean (=0.034), Perc50 (=0.046), and Perc90 (=0.040), with AUCs of 0.605, 0.592, and 0.652, respectively, than HER2-negative lesions. No significant differences were found in the histogram values for ER and PR statuses. Neither quantitative histogram analysis based on ADC maps nor qualitative visual heterogeneity assessment of DWI images was able to significantly differentiate between molecular subtypes, i.e., luminal A versus all other subtypes (luminal B, HER2-enriched, and triple negative) combined, luminal A and B combined versus HER2-enriched and triple negative combined, and triple negative versus all other types combined.
Histogram analysis and visual heterogeneity assessment cannot be used to differentiate molecular subtypes of invasive breast cancer.
研究扩散加权成像(DWI)表观扩散系数(ADC)图的直方图分析和异质性的可视评估是否可以预测浸润性乳腺癌的分子亚型。
在这项回顾性研究中,共纳入了 91 例在我院接受术前磁共振成像(MRI)加 DWI 检查的浸润性乳腺癌患者。两位放射科医生在共识的基础上对 ADC 图上的 2-D 感兴趣区(ROI)进行勾画。肿瘤也基于 DWI 的视觉评估被独立分为低异质性和高异质性。在 ADC 图 ROI 内通过直方图分析提取的一阶统计量(平均值、第 10 百分位数、第 50 百分位数、第 90 百分位数、标准差、峰度和偏度)和视觉评估的异质性与肿瘤受体状态(ER、PR 和 HER2 状态)以及分子亚型进行了相关性评估。
与 HER2 阴性病变相比,HER2 阳性病变的平均(=0.034)、Perc50(=0.046)和 Perc90(=0.040)值更高,其 AUC 分别为 0.605、0.592 和 0.652。在 ER 和 PR 状态的直方图值方面没有发现显著差异。基于 ADC 图的定量直方图分析和 DWI 图像的定性异质性评估均无法显著区分分子亚型,即 luminal A 与所有其他亚型(luminal B、HER2 富集型和三阴性)的组合、luminal A 和 B 的组合与 HER2 富集型和三阴性的组合以及三阴性与所有其他类型的组合。
直方图分析和异质性的可视评估不能用于区分浸润性乳腺癌的分子亚型。